HSIC vs INVX · P/E 24, rev $6.83B vs P/E 8.0, rev $483.9M
Henry Schein Inc (HSIC) versus Innovex International, Inc (INVX) — a side-by-side from cached financials, not a winner call.
Henry Schein Inc (HSIC) is a medical distribution company listed on NASDAQ.
Innovex International, Inc (INVX) is a oil & gas equipment & services company listed on US.
Latest reported HSIC revenue for 2026-06-27 was $6.83B. Net income was $201.0M. HSIC currently screens at market cap $9.11B and trailing P/E 24.2.
Latest reported INVX revenue for 2026-06-30 was $483.9M. Net income was $8.4M. INVX currently screens at market cap $1.10B and trailing P/E 8.0.
HSIC currently screens at market cap $9.11B and trailing P/E 24.2. INVX currently screens at market cap $1.10B and trailing P/E 8.0.
Not investment advice. Open the HSIC and INVX stock pages for the full models.
Not investment advice.